- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02668328
Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients
CGV in Newly Diagnosed Type 2 Diabetes Patients: Effect of Dietary Interventions in the Human Microbiome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
T2D poses a significant public health problem. Hyperglycemia is associated with a variety of vascular complications, but clinical trials of medication regimes designed to achieve near-normal HbA1c have been mostly negative. The lack of benefit observed in these trials may be due to the fact that they targeted HbA1c rather than glucose variability, and were conducted in patients with established T2D that had already experienced complications of the disease. In early T2D, management of postprandial glycemia may be particularly important for minimization of metabolic memory effects and preservation of beta cell function. Postprandial glycemia in early T2D is largely driven by dietary intake, but research findings that guide clinicians regarding the best dietary approach to prescribe are mixed. Studies done, to-date, have used one-size-fits-all dietary regimes that do not take into consideration the person's unique glycemic response to food. The investigators know from decades of research that behavioral methods are required to engage patients in lifestyle behavior change. The investigators argue that tailoring the approach to the participant's glycemic response and gut microbiome will enhance self-efficacy in ways that cannot be achieved through standard behavioral methods alone and, in turn, reduce glycemic variability and metabolic memory effects.
Co-PI Segal et al. demonstrated that subjects have high between-subject variability in postprandial response to the same food, suggesting that universal dietary recommendations are of limited utility for controlling elevated postprandial glucose. The machine learning algorithm devised by the group integrates multidimensional data to accurately predict personalized postprandial glycemic responses. In a subsequent validation study in 100 participants, they showed that a personally-tailored intervention based on the predicted response resulted in significantly improved postprandial glycemic response, and were accompanied by beneficial changes in gut microbiota.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 5 years or less since type 2 diabetes was diagnosed
Exclusion Criteria:
- more 5 years since type 2 diabetes was diagnosed
Study Plan
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral Intervention
The proposed study involves a 2-phase randomized clinical trial in adults with recently diagnosed T2D.
Participants will be randomized to a wait-list Control group, BI, or Tailored-BI.
In Phase 1, wait-list Control participants will receive 6 months of standard care; BI and Tailored-BI participants will receive 6 months of Active Intervention.
In Phase 2, wait-list Control group participants will cross-over to the delayed Tailored-BI, and the BI and Tailored-BI participants will enter a 6-month observation phase to examine maintenance effects of the intervention.
|
The intervention will enhance self-efficacy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean Amplitude of Glycemic Excursion (MAGE)
Time Frame: 1 week
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NYUmed
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus Type 2 in Obese
-
Sahlgrenska University Hospital, SwedenKarolinska Institutet; Imperial College London; University Hospital, Ghent; Universitair... and other collaboratorsCompletedDiabetes Mellitus Type 2 in ObeseSpain, Sweden, Belgium, United Kingdom
-
University of OxfordSecond NatureActive, not recruitingType 2 Diabetes Mellitus in ObeseUnited Kingdom
-
University of NottinghamMedical Research CouncilRecruitingType 2 Diabetes Mellitus in ObeseUnited Kingdom
-
NovMetaPharma Co., Ltd.CompletedDiabetes Mellitus Type 2 in ObeseUnited States
-
Hasan Kalyoncu UniversityRecruitingDiabetes Mellitus Type 2 in ObeseTurkey
-
Region StockholmRecruitingDiabetes Mellitus Type 2 in ObeseSweden
-
tarek mahdyCompletedDiabetes Mellitus Type 2 in Obese
-
Beijing Chao Yang HospitalCompleted
-
Chinese University of Hong KongCompleted
-
Radboud University Medical CenterNot yet recruitingDiabetes Mellitus Type 2 in ObeseNetherlands
Clinical Trials on Social Cognitive Theory Tailored Behavioral Intervention
-
Public Health Service of AmsterdamTerminatedSexual Risk Behavior for HIV-InfectionNetherlands
-
Palo Alto Medical FoundationNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Asthma
-
NYU Langone HealthCompleted
-
Robert H. FriedmanUniversity of North Carolina, Chapel HillCompletedCancerUnited States
-
University of Alabama at BirminghamConsortium of Multiple Sclerosis CentersCompletedMultiple SclerosisUnited States
-
NYU Langone HealthCompletedObesity | Type 2 Diabetes | Chronic Kidney Disease (CKD)United States
-
The Metis FoundationColorado State UniversityRecruitingMental Disorders | Obesity | Feeding and Eating Disorders | Overweight | Body Weight | Anxiety | Eating BehaviorUnited States
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States
-
Rabin Medical CenterAcademic College of Tel Aviv-Jaffa; Israel Cancer AssociationUnknownOvarian Cancer | Cancer of Cervix | Cancer of EndometriumIsrael
-
University GhentLithuanian University of Health Sciences; VU University of AmsterdamCompletedSexual and Reproductive Health ProblemsBolivia, Ecuador, Nicaragua